Side effects during R maintenance
. | Observation . | . | Maintenance . | . | ||
---|---|---|---|---|---|---|
Side effect . | Grades 1 + 2, % . | Grades 3 + 4, % . | Grades 1 + 2, % . | Grades 3 + 4, % . | ||
Allergy | 2 | 0 | 4 | 0 | ||
Exanthema | 5 | 0 | 6 | 0 | ||
Headache | 5 | 0 | 4 | 0 | ||
Granulocytopenia | 14 | 6 | 18 | 13 | ||
Anemia | 11 | 3 | 15 | 3 | ||
Lymphocytopenia | 10 | 16 | 3 | 22 | ||
Thrombocytopenia | 13 | 3 | 10 | 4 | ||
Leukocytopenia | 28 | 5 | 28 | 10 | ||
Infection | 16 | 3 | 24 | 4 | ||
Fever | 3 | 0 | 7 | 4 | ||
Nausea/vomiting | 5 | 0 | 8 | 0 | ||
Mucositis | 2 | 0 | 2 | 0 | ||
Diarrhea | 5 | 2 | 2 | 0 | ||
Cardiac dysfunction | 0 | 0 | 3 | 1 | ||
Neurotoxicity | 13 | 2 | 13 | 0 | ||
Pulmonary toxicity | 2 | 0 | 6 | 1 | ||
Nephrotoxicity | 0 | 0 | 1 | 0 | ||
Alkaline phosphatase | 2 | 0 | 6 | 0 | ||
ALT | 6 | 0 | 10 | 1 | ||
AST | 3 | 0 | 4 | 0 | ||
Bilirubin | 0 | 0 | 3 | 0 | ||
LDH | 13 | 0 | 18 | 0 | ||
Alopecia | 2 | 3 | 3 | 0 |
. | Observation . | . | Maintenance . | . | ||
---|---|---|---|---|---|---|
Side effect . | Grades 1 + 2, % . | Grades 3 + 4, % . | Grades 1 + 2, % . | Grades 3 + 4, % . | ||
Allergy | 2 | 0 | 4 | 0 | ||
Exanthema | 5 | 0 | 6 | 0 | ||
Headache | 5 | 0 | 4 | 0 | ||
Granulocytopenia | 14 | 6 | 18 | 13 | ||
Anemia | 11 | 3 | 15 | 3 | ||
Lymphocytopenia | 10 | 16 | 3 | 22 | ||
Thrombocytopenia | 13 | 3 | 10 | 4 | ||
Leukocytopenia | 28 | 5 | 28 | 10 | ||
Infection | 16 | 3 | 24 | 4 | ||
Fever | 3 | 0 | 7 | 4 | ||
Nausea/vomiting | 5 | 0 | 8 | 0 | ||
Mucositis | 2 | 0 | 2 | 0 | ||
Diarrhea | 5 | 2 | 2 | 0 | ||
Cardiac dysfunction | 0 | 0 | 3 | 1 | ||
Neurotoxicity | 13 | 2 | 13 | 0 | ||
Pulmonary toxicity | 2 | 0 | 6 | 1 | ||
Nephrotoxicity | 0 | 0 | 1 | 0 | ||
Alkaline phosphatase | 2 | 0 | 6 | 0 | ||
ALT | 6 | 0 | 10 | 1 | ||
AST | 3 | 0 | 4 | 0 | ||
Bilirubin | 0 | 0 | 3 | 0 | ||
LDH | 13 | 0 | 18 | 0 | ||
Alopecia | 2 | 3 | 3 | 0 |
No differences were statistically significant.
ALT indicates alanine aminotransferase; AST, aspartate aminotransferase.